Antimicrobial susceptibility and molecular analysis of Enterococcus faecalis originating from endodontic infections in Finland and Lithuania

被引:25
作者
af Geijersstam, AHR
Ellington, MJ
Warner, M
Woodford, N
Haapasalo, M
机构
[1] Inst Clin Odontol, Dept Endodont, Oslo, Norway
[2] Hlth Protect Agcy, Ctr Infect, Antibiot Resistance Monitoring & Reference Lab, London, England
[3] Univ British Columbia, Fac Dent, Div Endodont, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada
来源
ORAL MICROBIOLOGY AND IMMUNOLOGY | 2006年 / 21卷 / 03期
关键词
apical periodontitis; enterococcal sensitivity; Lsa-mutation;
D O I
10.1111/j.1399-302X.2006.00271.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/aims: Enterococcus faecalis strains with multiple antibiotic resistances can cause infections that are difficult to treat. The microbial flora in treatment-resistant apical periodontitis is dominated by E. faecalis, and is a potential source of infections at other sites. Material and methods: Sensitivities to a range of antibiotics were determined for 59 endodontic E. faecalis isolates from Finland and Lithuania. The DNA sequence of the gene responsible for the species' intrinsic quinupristin-dalfopristin resistance, lsa, was determined from two isolates with diminished resistance. Four pairs of isolates from the same root canal were typed by pulsed-field gel electrophoresis. Results: A high prevalence of resistance to rifampicin was found, whereas all isolates were susceptible or showed intermediate susceptibility to penicillin and ampicillin and four isolates were unusually susceptible to cefotaxime. No vancomycin or high-level gentamicin resistance was detected. Nine of 59 isolates were susceptible to quinupristin-dalfopristin. A fully quinupristin-dalfopristin-susceptible isolate also susceptible to clindamycin produced a truncated Lsa polypeptide, and an isolate with borderline quinupristin-dalfopristin-susceptibility had mutations proximal to the predicted ribosomal binding site. Pulsed-field gel electrophoresis showed that the same root canal could harbor two different strains of E. faecalis during the course of the same infection. Conclusion: Despite the differing antibiotic usage in Finland and Lithuania, E. faecalis from endodontic infections in these countries showed similar susceptibility patterns with levels of resistance considered typical for the species, and decreased resistance to clindamycin and quinupristin-dalfopristin as well as lesions in the lsa gene which were similar to those described in other clinical isolates.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 40 条
[1]   Quinupristin/dalfopristin: A therapeutic review [J].
Allington, DR ;
Rivey, MP .
CLINICAL THERAPEUTICS, 2001, 23 (01) :24-+
[2]   BSAC standardized disc susceptibility testing method (version 4) [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :60-76
[3]   Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium [J].
Bozdogan, B ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2720-2725
[4]   Antibiotic policies in Central Eastern Europe [J].
Cizman, M ;
Beovic, B ;
Krcmery, V ;
Barsic, B ;
Tamm, E ;
Ludwig, E ;
Pelemis, M ;
Karovski, K ;
Grzesiowski, P ;
Gardovska, D ;
Volokha, A ;
Keuleyan, E ;
Stratchounski, L ;
Dumitru, C ;
Titov, LP ;
Usonis, V ;
Dvorák, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (03) :199-204
[5]   Identification and antimicrobial susceptibility of enterococci isolated from the root canal [J].
Dahlén, G ;
Samuelsson, W ;
Molander, A ;
Reit, C .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (05) :309-312
[6]   Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A [J].
Dina, J ;
Malbruny, B ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2307-2309
[7]   In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification [J].
Duh, RW ;
Singh, KV ;
Malathum, K ;
Murray, BE .
MICROBIAL DRUG RESISTANCE, 2001, 7 (01) :39-46
[8]  
Engstrom B., 1964, ODONTOL REVY, V15, P87
[9]  
*FINRES, BACT RES ANT AG FINL
[10]   The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals [J].
Gaynes, R .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (04) :757-&